Cryptococcal meningitis: Validation of new therapeutic regimens

(ANRS) The Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) trial funded by the Medical Research Council (UK) and ANRS (France) has highlighted the benefits of new therapeutic regimens in the treatment of cryptococcal meningitis, a frequent and severe opportunistic disease in patients living with HIV. In light of these findings, reported in the March 15, 2018 issue of the New England Journal of Medicine, the WHO has changed its guidelines regarding treatment of this fungal infection.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news